Zymeworks Inc (ZYME) Live Share Price, Invest From India

Zymeworks Inc Stock Performance

as on October 22, 2025 at 1:29 am IST

Day's Low
Day's High
$17.93
Day's Price Range
$18.45
$17.95
0.11%
Downside
2.79%
Upside
52 Week's Low
52 Week's High
$9.03
52-Week Price Range
$19.5
$17.95
49.69%
Downside
8.64%
Upside

Zymeworks Inc share price movements today

Previous Close: $18.32
Open: $18.45
Volume: 596.0K
Day's Low - High: $17.93 - $18.45
52 Week Low - High: $9.03 - $19.5

Zymeworks Inc Historical Returns

1 Month Return: + 8.47 %
3 Month Return: + 25.21 %
1 Year Return: + 36.45 %
3 Year Return: + 186.88 %
5 Year Return: 0 %

Zymeworks Inc Stock Fundamentals & Key Indicators

Check Zymeworks Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.4B

EPS (TTM)

-0.7753

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.51

Industry PE ratio

0.4929787234042553

PEG Ratio

EBITDA

-72.6M

Revenue (TTM)

122.9M

Profit Margin

-59.96%

Return On Equity TTM

60900.00%

Zymeworks Inc Stock Valuation

Track how Zymeworks Inc P/E has moved over time to understand its valuation trends.

Zymeworks Inc in the last 5 years

Overview
Trends

Lowest (-12.28x)

June 30, 2025

Today (-3.51x)

October 22, 2025

Industry (0.49x)

October 22, 2025

Highest (3.97x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -3.51x

Zymeworks Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Zymeworks Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Zymeworks Inc	BUY	$1.4B	NA	-3.51	-59.96%
Insmed Incorporated	BUY	$34.9B	342.12%	-16.34	-259.82%
Alnylam Pharmaceuticals, Inc.	BUY	$64.4B	252.94%	-505.15	-12.96%
Vertex Pharmaceuticals Incorporated	BUY	$107.5B	102.91%	29.68	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$61.3B	0.63%	14.58	31.37%

Stock Returns calculator for Zymeworks Inc Stock including INR - Dollar returns

The Zymeworks Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Zymeworks Inc investment value today

Current value as on today

₹1,41,413

Returns

₹41,413

(+41.41%)

Returns from Zymeworks Inc Stock

₹36,606 (+36.61%)

Dollar Returns*

₹4,808 (+4.81%)

Analyst Recommendation on Zymeworks Inc Stock

Based on 14 analysts

BUY

71.43%

Buy

28.57%

Hold

0.00%

Sell

Based on 14 analysts, 71.43% of analysts recommend a 'BUY' rating for Zymeworks Inc. Average target price of $23.68

Zymeworks Inc Share Price Target

Get share price movements and forecasts by analysts on Zymeworks Inc.

What analysts predicted

24.2%UPSIDE

Target Price

$23.68

Current Price

$17.95

Analyzed by

14 Analysts

Target

$23.68

Zymeworks Inc target price $23.68, a slight upside of 24.2% compared to current price of $17.95. According to 14 analysts rating.

Zymeworks Inc Stock’s Investor Sentiment and Interest

Search interest for Zymeworks Inc Stock has increased by 18% in the last 30 days, reflecting an upward trend in search activity.

Time period: September 22, 2025 to October 22, 2025

Change:18% versus previous 30 day period

Zymeworks Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	35	7	16	16	10	19	16	31	27	48
Gross Profit	-9	-32	-16	-8	-22	16	13	27	27	48
Operating Income	-27	-54	-33	-23	-37	-25	-34	-22	-25	0
EBITDA	-24	-49	-21	-21	-36	-23	-26	-14	-22	2
Interest Expense	7	-	-	7	-	-	-	-	-	-
Depreciation	2	4	6	3	2	2	2	3	3	3
Income Before Tax	-22	-49	-27	-19	-31	-37	-29	-17	-22	2
Income Tax Expense	1	1	-1	-4	0	0	0	5	0	0
Net Income	-24	-51	-28	-14	-31	-37	-29	-23	-22	2
Net Profit Margin	-68.45%	-730.53%	-173.80%	-85.56%	-315.58%	-195.84%	-186.56%	-75.75%	-83.50%	4.76%

Zymeworks Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	9	11	51	53	29	38	26	412	76	76
Gross Profit	-14	-24	10	53	-87	38	26	412	-66	65
Operating Income	-19	-37	-8	-33	-151	-187	-215	130	-138	-119
EBITDA	-18	-36	-6	-29	-143	-177	-206	142	-120	-105
Interest Expense	0	0	1	0	11	17	12	3	-	-
Depreciation	-	-	2	3	7	10	12	12	17	11
Income Before Tax	-19	-38	-9	-34	-146	-180	-212	135	-119	-116
Income Tax Expense	0	-5	0	2	0	0	0	10	0	6
Net Income	-19	-33	-10	-36	-145	-180	-211	124	-118	-122
Net Profit Margin	-198.45%	-307.10%	-20.10%	-68.95%	-492.27%	-463.54%	-794.01%	30.14%	-156.13%	-160.80%

Zymeworks Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-51	-28	-14	-31	-37	-29	-23	-22	2
Operating Cash Flow	-6	-42	13	-37	-24	-5	-41	-3	12
Investing Cash Flow	-60	-7	-1	-7	-19	72	-6	12	8
Financing Cash Flow	27	1	50	2	1	-14	-8	1	1
Change in Cash	-39	-47	63	-42	-43	51	-56	10	22

Zymeworks Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-33	-10	-36	-145	-180	-211	124	-118	-122
Operating Cash Flow	-35	0	24	-81	-151	-192	144	-118	-110
Investing Cash Flow	-25	-30	-109	-25	-43	144	-53	-207	38
Financing Cash Flow	64	49	91	193	308	8	108	81	-20
Change in Cash	4	19	6	86	113	-40	199	-243	-91

Global Institutional Holdings in Zymeworks Inc

Funds	Holdings
EcoR1 Capital, LLC	30.33%
Rubric Capital Management LP	6.22%
Bvf Inc	5.69%
Morgan Stanley - Brokerage Accounts	5.52%
Redmile Group, LLC	5.48%

See all

Insights on Zymeworks Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 5 quarters, -37.68M → 2.31M (in $), with an average increase of 283.5% per quarter
POSITIVE IMPACT
Price Rise
In the last 3 years, ZYME stock has moved up by 186.9%
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, ZYME has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 27.11M → 48.72M (in $), with an average increase of 44.4% per quarter
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 59.9% return, outperforming this stock by 23.4%

About Zymeworks Inc

zymeworks is a privately held biotherapeutics company that is developing best-in-class azymetric™ bi specific antibodies and antibody drug conjugates for the treatment of oncology, autoimmunity and inflammatory diseases. the company’s novel azymetric™ and albucore™ platforms, and its proprietary zymecad™ structure-guided protein engineering technology, enable the development of highly potent bi-specific antibodies and multivalent protein therapeutics targeted across a range of indications. zymeworks is focused on accelerating its preclinical biotherapeutics pipeline through in-house research and development programs and strategic collaborations. more information on zymeworks can be found at www.zymeworks.com.

Organisation	Zymeworks Inc
Headquarters	108 Patriot Drive, Middletown, DE, United States, 19709
Industry	Health Technology
CEO	Mr. Kenneth H. Galbraith C.A.
E-voting on shares	Click here to vote

Key Management of Zymeworks Inc

Name	Title
Mr. Mark Hollywood	Executive VP and Head of Technical & Manufacturing Operations
Ms. Shrinal Inamdar	Director of Investor Relations
Dr. Jeffrey Smith M.D.	Executive VP & Chief Medical Officer
Ms. Laura O'Connor	Vice President of Human Resources & DEI
Mr. Kenneth H. Galbraith C.A.	Chairman of the Board, CEO & President
Ms. Leone D. Patterson CPA, M.B.A.	Executive VP and Chief Business & Financial Officer
Dr. Paul A. Moore Ph.D.	Chief Scientific Officer
Mr. Daniel Dex J.D., Ph.D.	Senior VP, Corporate Secretary & General Counsel
Diana Papove	Senior Manager of Corporate Communications
Dr. Lindsey Foulkes B.Sc., Ph.D.	Vice President of Corporate Development

FAQs

What is Zymeworks Inc share price today?

Zymeworks Inc share price today is $17.95 as on October 22, 2025 at 1:29 am IST at the close of the market. Zymeworks Inc share today touched a day high of $18.45 and a low of $17.93.

What is the 52 week high and 52 week low for Zymeworks Inc share?

Zymeworks Inc share touched a 52 week high of $19.5 on October 14, 2025 and a 52 week low of $9.03 on April 10, 2025. Zymeworks Inc stock price today i.e. October 22, 2025 at 1:29 am IST is closed at $17.95,which is 7.95% down from its 52 week high and 98.78% up from its 52 week low.

What is Zymeworks Inc's market capitalisation today?

Zymeworks Inc market capitalisation is $0.00T as on October 22, 2025 at 1:29 am IST.

How to invest in Zymeworks Inc Stock (ZYME) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Zymeworks Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Zymeworks Inc Shares that will get you 0.0836 shares as per Zymeworks Inc share price of $17.95 per share as on October 22, 2025 at 1:29 am IST.

What is the minimum amount required to buy Zymeworks Inc Stock (ZYME) from India?

Indian investors can start investing in Zymeworks Inc (ZYME) shares with as little as ₹87.965 or $1 (as of October 22, 2025 at 1:37 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹879.65 in Zymeworks Inc stock (as per the Rupee-Dollar exchange rate as on October 22, 2025 at 1:37 pm IST). Based on Zymeworks Inc share’s latest price of $17.95 as on October 22, 2025 at 1:29 am IST, you will get 0.5571 shares of Zymeworks Inc. Learn more about fractional shares .